Home › Transthyretin-Related Hereditary Amyloidosis › Connecticut › New Haven
Transthyretin-Related Hereditary Amyloidosis clinical trials in New Haven, CT
3 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, New Haven
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Yale University School of Medicine - Section of Cardiology, New Haven
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Yale University School of Medicine, New Haven
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- Los Angeles, CA5 studies
- New York City, NY5 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Portland, OR4 studies
- San Diego, CA4 studies
- Boston, MA4 studies
- Dallas, TX4 studies
- St. Louis, MO3 studies
- Kansas City, MO3 studies
- Washington, DC3 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.